Sharon Apel’s Story: How Radioimmunotherapy Works for Lymphoma
Options used after chemotherapy are typically less effective
“These patients are generally considered to be incurable. When patients start failing chemotherapy, subsequent responses to new regimens tend to be less good, and of shorter duration,” said Susan Knox, associate professor of radiation oncology. Knox worked alongside professor Ronald Levy and radiology professor Michael Goris in several clinical trials aimed at improving treatment for advanced non-Hodgkin lymphoma and solid tumors.